Butyrylcholinesterase from equine serum, lyophilized powder, >=900 units/mg protein

Analysis Note

Protein determined by biuret

Application

Selective inhibition of BChE activity can be used in the detection of organophosphates. Its use in the treatment of organophosphate toxicity has been explored. It has been reported that the level of BChE in human blood correlates to the degree of protection against potentially toxic nerve agents. Cholinesterases have also been investigated for their role in Alzheimer’;s disease.

Biochem/physiol Actions

Butyrylcholinesterase (BChE) is a serine hydrolase that is structurally similar to acetylcholinesterase (AChE), but differs in substrate specificities and inhibitor sensitivities.BChE can, unlike AChE, efficiently hydrolyze larger esters of choline such as butyrylcholine and benzoylcholine. The enzyme is a tetrameric glycoprotein with four equal subunits (110 kDa each). The enzyme is activated by Ca2+ and Mg2+. The activity is constant over the pH range of 6.0-8.0. It is inhibited by betaine, nicotine, organophosphates, and carbamate.

Packaging

1000, 5000 units in glass bottle

Physical form

Highly purified; contains buffer salts

Unit Definition

One unit will hydrolyze 1.0?µmole of butyrylcholine to choline and butyrate per min at pH?8.0 at 37?°C. The activity obtained using butyrylcholine as substrate is ~2.5 times that obtained using acetylcholine.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level Manufacturer Composition Storage Temp. Solubility Form Price Quantity
3579116 Butyrylcholinesterase from equine serum, lyophilized powder, >=900 units/mg protein 300 SIGMA-ALDRICH Protein, ≥10% −20°C
£553.71 (exc VAT) per EACH
-
+
3579117 Butyrylcholinesterase from equine serum, lyophilized powder, >=900 units/mg protein 300 SIGMA-ALDRICH Protein, ≥10% −20°C
Click Add to Quote for price and delivery
-
+